Abivax announces the resumption of its liquidity contract - Abivax (NASDAQ:ABVX)
Abivax announces the resumption of its liquidity contract Paris, France, November 21, 2023 – 8:30 a.m. CET – Abivax SA (NASDAQ:ABVX) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on